Canada Markets closed
  • S&P/TSX

    21,212.39
    +24.20 (+0.11%)
     
  • S&P 500

    4,549.78
    +13.59 (+0.30%)
     
  • DOW

    35,603.08
    -6.26 (-0.02%)
     
  • CAD/USD

    0.8084
    -0.0036 (-0.4487%)
     
  • BTC-CAD

    77,691.09
    -4,447.78 (-5.41%)
     
  • CMC Crypto 200

    1,490.38
    -44.27 (-2.88%)
     
  • GOLD FUTURES

    1,783.80
    +1.90 (+0.11%)
     
  • RUSSELL 2000

    2,296.18
    +6.42 (+0.28%)
     
  • 10-Yr Bond

    1.6760
    +0.0400 (+2.44%)
     
  • VOLATILITY

    15.01
    -0.48 (-3.10%)
     
  • FTSE

    7,190.30
    -32.80 (-0.45%)
     
  • NIKKEI 225

    28,708.58
    -546.97 (-1.87%)
     
  • CAD/EUR

    0.6951
    -0.0014 (-0.20%)
     

Dr. Robert Dawes Joins ReedGroup as Chief Medical Officer

·2 min read

Leading Absence Management Firm Accelerates Clinical Management Strategy with Chief Medical Officer Hire

WESTMINSTER, Colo., September 21, 2021--(BUSINESS WIRE)--ReedGroup®, a leading absence management provider and publisher of MDGuidelines® evidence-based guidelines and formularies, announced Dr. Robert Dawes will join ReedGroup as the company’s new Chief Medical Officer. Dr. Dawes, a well-known and esteemed clinician, will be responsible for managing and building forward ReedGroup’s clinical management strategy. Dr. Dawes will report to CEO Sandy Callahan, and serve on the executive management team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005851/en/

Dr. Robert Dawes, chief medical officer, ReedGroup (Photo: Business Wire)

"We continue to elevate our focus on medically sound determinations and claim administration, particularly given the current environment in which disability claim incidence is rising and employers need expertise in determining the medical necessity of leaves. Dr. Dawes will bring a compelling clinical vision given his years of expertise and proven leadership," stated Callahan.

"My long-tenured commitment to MDGuidelines as the gold standard in clinical guidelines was only one of the many reasons I am excited about joining ReedGroup," shared Dr. Dawes. "ReedGroup’s Fortune 100 customer base and the increasing complexity all large employers are facing regarding absence makes this opportunity an exciting one. My passion for clinical case management innovation and training for clinical case managers in their day-to-day work makes this a perfect fit."

Dr. Dawes has extensive medical and clinical experience, has a Psy.D. in Clinical Psychology, and most recently was the Chief Medical Officer of Aflac.

About ReedGroup and MDGuidelines

ReedGroup, a wholly owned subsidiary of The Guardian Life Insurance Company of America®, is a leading leave of absence management organization providing outsourcing, co-sourcing, software, and services to nearly half of the Fortune 100 companies.

ReedGroup’s product, MDGuidelines, is the industry’s leading solution for total health management and workplace productivity. MDGuidelines features the world’s most trusted disability durations, predictive modeling, analytic services, drug formulary, and evidence-based clinical practice guidelines from ACOEM, and is used around the world by healthcare payers, providers, and employers to help patients return to activity quickly and safely. MDGuidelines is a proven approach to managing and measuring the impact of evidence-based care across entire populations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005851/en/

Contacts

Rachel Biederman, ReedGroup
D: 303-947-4146
email: rachel.biederman@reedgroup.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting